Skip to main content

UBS Group AG

Position in UNCY — Unicycive Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in UNCY

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$325,378
+$197,437 QoQ
Shares Held
69,377
+256.8% QoQ
Ownership
0.249%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 80 holders
Holding Since
Sep 2021
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in UNCY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. UNCY ranks #316 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in UNCY

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $325,378 69,377
2026-03-31 $127,941 19,444
2025-12-31 $114,851 19,905
2025-09-30 $23,740 5,445
2025-03-31 $5,492 9,552
2024-12-31 $1 1
2024-09-30 $0 1
2024-06-30 $1 1
2024-03-31 $6,054 4,387
2023-12-31 $152 176
2023-09-30 $617 718
2023-06-30 $1,496 1,169
2022-09-30 $702 1,190
2022-06-30 $3,727 4,491
2021-12-31 $10,862 5,273
2021-09-30 $1,757 621